Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) SHH

Currency In CNY

AD

Valuation

Market Cap11.63B
Enterprise Value12.52B
P/E Ratio14.69
PEG Ratio0.16
Price/Sales Ratio1.34
Price/Book Ratio1.43
Enterprise/Revenue1.43
Enterprise/EBITDA7.7

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.09
Operating Margin0.11
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.1

Income Statement

Revenue10.55B
Revenue/Share8.44
Gross Profit4.73B
EBITDA1.89B
Net Income540.71M
Diluted EPS0.46

Balance Sheet

Total Cash1.14B
Total Cash/Share0.98
Total Debt1.96B
Total Debt/Equity0.22
Current Ratio0.93
Book Value Per Share8.11

Price History

52-Week Change5.1
52-Week High15
52-Week Low9.35
Moving Average 50 Days12.16
Moving Average 200 Days10.9

Statistics

Average Volume43.68M
Shares Outstanding1.18B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.21
Trailing Annual Dividend Yield1.89
Payout Ratio0.33
Last Split Factor8:5
Last Split DateMay 25, 2012
AD